Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.5000
+0.0100 (2.04%)
Sep 4, 2026, 3:38 PM EST
Vaxart Market Cap
Vaxart has a market cap or net worth of $120.2 million as of September 8, 2026. Its market cap has increased by 36.69% in one year.
Market Cap
120.20M
Enterprise Value
68.77M
Revenue
243.07M
Ranking
n/a
PE Ratio
3.06
Stock Price
$0.50
ChartMarket Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 120.20M, an increase of 99.18%. That is a compound annual growth rate of 8.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 120.20M | 44.60% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 289.36M |
| CytoDyn | 274.48M |
| Glorywin Entertainment Group | 234.77M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 80.25M |
| Sangamo Therapeutics | 66.70M |
| Nuo Therapeutics | 58.60M |
| Arch Biopartners | 50.27M |